Business Wire

Sesen Bio Announces Successful Application Orientation Meeting (AOM) with the FDA for Vicineum™

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today reported ...
AZoNano

Bringing Bio-AFM to Nanoscience Applications

Bio-AFM is a cutting-edge technique rooted in the rich history of atomic force microscopy. Here, we discuss its applications to nanoscience. Studying nanoscale biological specimens has been important ...
Business Wire

bluebird bio Submits Biologics License Application (BLA) to FDA for lovotibeglogene autotemcel (lovo-cel) for Patients with Sickle Cell Disease (SCD) 12 years and Older with a ...

SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) today announced the submission of its Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ...